Trial · NCT00259298
Results by group85
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 85
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Whole skeleton, baseline to 3 months, n=10 | 25.02 | Inter-Quartile Range 14.21 to 30.73 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Whole skeleton, baseline to 24 months, n=9 | 3.52 | Inter-Quartile Range -8.27 to 11.93 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Whole skeleton, 3 months to 18 months, n=10 | 10.44 | Inter-Quartile Range 7.83 to 21.00 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Whole skeleton, 18 months to 24 months, n=9 | -22.20 | Inter-Quartile Range -24.35 to -18.39 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Skull, baseline to 3 months, n=8 | 72.25 | Inter-Quartile Range 42.19 to 106.56 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Skull, baseline to 18 months, n=8 | 128.44 | Inter-Quartile Range 97.38 to 162.55 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Skull, baseline to 24 months, n=7 | 21.20 | Inter-Quartile Range 8.00 to 54.90 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Skull, 3 months to 18 months, n=8 | 31.01 | Inter-Quartile Range 17.65 to 47.29 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Skull, 18 months to 24 months, n=7 | -37.87 | Inter-Quartile Range -45.64 to -32.14 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Mandible, baseline to 3 months, n=8 | 65.94 | Inter-Quartile Range 26.56 to 106.76 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Mandible, baseline to 18 months, n=8 | 60.99 | Inter-Quartile Range 31.25 to 127.78 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Mandible, baseline to 24 months, n=7 | 21.05 | Inter-Quartile Range -6.90 to 82.35 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Mandible, 3 months to 18 months, n=8 | 4.55 | Inter-Quartile Range -3.25 to 15.13 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Mandible, 18 months to 24 months, n=7 | -17.39 | Inter-Quartile Range -25.81 to -10.00 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Spine, baseline to 3 months, n=10 | 17.31 | Inter-Quartile Range 0.46 to 35.53 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Spine, baseline to 18 months, n=10 | 33.81 | Inter-Quartile Range 7.53 to 57.99 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Spine, baseline to 24 months, n=9 | 16.94 | Inter-Quartile Range -0.14 to 32.99 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Spine, 3 months to 18 months, n=10 | 14.10 | Inter-Quartile Range -0.23 to 20.00 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Spine, 18 months to 24 months, n=9 | -9.42 | Inter-Quartile Range -15.31 to 8.31 | percentage of change of plasma clearance |
| Change in Skeletal Plasma Clearance of 99m Technetium Methylene Diphosphonate (99m Tc-MDP) in the Whole Skeleton, Skull, Mandible, Spine, Pelvis, Upper Extremities, and Lower Extremities | Teriparatide | Pelvis, baseline to 3 months, n=10 | 20.26 | Inter-Quartile Range 5.00 to 43.59 | percentage of change of plasma clearance |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00259298/results